175 related articles for article (PubMed ID: 24998431)
1. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
2. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.
Liu Z; Chen C; Yang H; Zhang Y; Long J; Long X; Fang W
Proteomics; 2012 Nov; 12(22):3416-25. PubMed ID: 22997098
[TBL] [Abstract][Full Text] [Related]
3. [Screening for differentially expressed proteins in nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis].
Yi H; Cheng AL; Huang WG; Zhang PF; Li MY; Peng F; Li F; Li C; Chen ZC; Xiao ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):375-83. PubMed ID: 18544839
[TBL] [Abstract][Full Text] [Related]
4. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Tang CE; Tan T; Li C; Chen ZC; Ruan L; Wang HH; Su T; Zhang PF; Xiao ZQ
Oncol Rep; 2010 Aug; 24(2):495-500. PubMed ID: 20596638
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3γ as a novel biomarker in nasopharyngeal carcinoma.
Wu Z; Weng D; Li G
J Proteomics; 2013 May; 83():26-36. PubMed ID: 23500129
[TBL] [Abstract][Full Text] [Related]
6. [The expressions of alpha-enolase in the nasopharyngeal cancer tissue].
Cheng C; Long X; Li X; Xie M; Guo M
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 25(12):554-6. PubMed ID: 21950004
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma.
Li XM; Huang WG; Yi H; Cheng AL; Xiao ZQ
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1763-75. PubMed ID: 19529960
[TBL] [Abstract][Full Text] [Related]
8. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
[TBL] [Abstract][Full Text] [Related]
9. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
10. Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach.
Chen Y; Tang CE; Ouyang GL; Ruan L; Li MY; Zhang PF; Li C; Yi H; Peng F; Li JL; Chen ZC; Xiao ZQ
Med Oncol; 2009 Dec; 26(4):463-70. PubMed ID: 19096942
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Peng X; Gong FM; Ren M; Ai P; Wu S; Tang J; Hu X
Anticancer Drugs; 2016 Sep; 27(8):748-55. PubMed ID: 27333594
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Yi B; Xiao ZQ
Clin Cancer Res; 2008 Jan; 14(2):435-45. PubMed ID: 18223218
[TBL] [Abstract][Full Text] [Related]
13. A Review: Proteomics in Nasopharyngeal Carcinoma.
Chen ZT; Liang ZG; Zhu XD
Int J Mol Sci; 2015 Jul; 16(7):15497-530. PubMed ID: 26184160
[TBL] [Abstract][Full Text] [Related]
14. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
15. iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.
Cai XZ; Zeng WQ; Xiang Y; Liu Y; Zhang HM; Li H; She S; Yang M; Xia K; Peng SF
J Cell Biochem; 2015 Jul; 116(7):1431-41. PubMed ID: 25648846
[TBL] [Abstract][Full Text] [Related]
16. Identification of radioresistance-associated proteins in human nasopharyngeal carcinoma cell lines by proteomic analysis.
Li L; Huang S; Zhu X; Zhou Z; Liu Y; Qu S; Guo Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):380-4. PubMed ID: 23464856
[TBL] [Abstract][Full Text] [Related]
17. Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma.
Li M; Li C; Li D; Xie Y; Shi J; Li G; Guan Y; Li M; Zhang P; Peng F; Xiao Z; Chen Z
Clin Exp Metastasis; 2012 Dec; 29(8):865-77. PubMed ID: 22706927
[TBL] [Abstract][Full Text] [Related]
18. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
19. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
